Who Owns Starling Oncology Stock?
NASDAQ: STLNHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 48.22%
- Held by insiders
- 15.19%
- Institutional holders
- 174
- Institutions 48.2%
- Insiders 15.2%
- Public and other 36.6%
Who owns Starling Oncology stock?
Institutional investors own about 48.2% of Starling Oncology's shares, spread across 174 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 15.19% of STLN.
The largest institutional holders are Blackrock Inc. (4.66%), Deerfield Management Company, L.P (3.29%) and Vanguard Capital Management LLC (3.20%). Together, the top 10 institutions control 23.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their STLN positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of STLN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 4.75M | 4.66% | +7.5% |
| Deerfield Management Company, L.P | 3.36M | 3.29% | 0.0% |
| Vanguard Capital Management LLC | 3.27M | 3.20% | -6.1% |
| Josh Arnold Investment Consultant, Llc | 2.46M | 2.42% | 0.0% |
| Geode Capital Management, LLC | 2.11M | 2.07% | +11.1% |
| State Street Corporation | 1.98M | 1.94% | +27.4% |
| Goldman Sachs Group Inc | 1.74M | 1.70% | +28.4% |
| Wexford Capital LP | 1.71M | 1.68% | 0.0% |
| Marshall Wace LLP | 1.22M | 1.20% | +257.2% |
| Renaissance Technologies, LLC | 1.18M | 1.16% | -13.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of STLN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.40M | 2.35% |
| iShares Trust-iShares Russell 2000 ETF | 2.01M | 1.97% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 1.03M | 1.01% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 838.32K | 0.82% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 794.69K | 0.78% |
| Fidelity Select Portfolios-Select Health Care Services Portfolio | 627.60K | 0.62% |
| iShares Trust-iShares Russell 2000 Growth ETF | 555.66K | 0.54% |
| Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF | 486.12K | 0.48% |
| Northern Lights Fund Trust IV-Inspire Fidelis Multi Factor ETF | 459.34K | 0.45% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 439.25K | 0.43% |
Frequently asked questions
Who is the largest shareholder of Starling Oncology?
Blackrock Inc. is the largest institutional shareholder of STLN, owning 4.66% of shares outstanding (4.75M shares) as of its latest 13F filing.
What percentage of Starling Oncology is owned by institutions?
Institutions own about 48.2% of STLN shares and 56.9% of the public float.
How much of Starling Oncology do insiders own?
Insiders, such as officers and directors, own about 15.19% of STLN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.